Join Growin Stock Community!

Cardio diagnostics holdings, inc.CDIO.US Overview

US StockHealthcare
(No presentation for CDIO)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

CDIO AI Insights

CDIO Overall Performance

CDIO AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

CDIO Recent Performance

-19.31%

Cardio diagnostics holdings, inc.

0.05%

Avg of Sector

-0.31%

S&P500

CDIO PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

CDIO Key Information

CDIO Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

CDIO Profile

Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.

Price of CDIO

CDIO FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

CDIO Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-3.59
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
757.87
PB Ratio
1.17
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
100.00%
Net Margin
-41516.33%
Revenue Growth (YoY)
-55.78%
Profit Growth (YoY)
-55.78%
3-Year Revenue Growth
-100.00%
3-Year Profit Growth
-100.00%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-3.59
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
757.87
PB Ratio
1.17
Price-to-FCF
-
Gross Margin
100.00%
Net Margin
-41516.33%
Revenue Growth (YoY)
-55.78%
Profit Growth (YoY)
-55.78%
3-Year Revenue Growth
-100.00%
3-Year Profit Growth
-100.00%
  • When is CDIO's latest earnings report released?

    The most recent financial report for Cardio diagnostics holdings, inc. (CDIO) covers the period of 2025Q3 and was published on 2025/09/30. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating CDIO's short-term business performance and financial health. For the latest updates on CDIO's earnings releases, visit this page regularly.

  • What is the operating profit of CDIO?

    According to the latest financial report, Cardio diagnostics holdings, inc. (CDIO) reported an Operating Profit of -1.71M with an Operating Margin of -59,950.86% this period, representing a decline of 21.48% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is CDIO's revenue growth?

    In the latest financial report, Cardio diagnostics holdings, inc. (CDIO) announced revenue of 2.86K, with a Year-Over-Year growth rate of -56.61%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does CDIO have?

    As of the end of the reporting period, Cardio diagnostics holdings, inc. (CDIO) had total debt of 486.6K, with a debt ratio of 0.06. Short-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does CDIO have?

    At the end of the period, Cardio diagnostics holdings, inc. (CDIO) held Total Cash and Cash Equivalents of 6.37M, accounting for 0.72 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does CDIO go with three margins increasing?

    In the latest report, Cardio diagnostics holdings, inc. (CDIO) did not achieve the “three margins increasing” benchmark, with a gross margin of 100%%, operating margin of -59,950.86%%, and net margin of -60,053.8%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess CDIO's profit trajectory and future growth potential.

  • Is CDIO's EPS continuing to grow?

    According to the past four quarterly reports, Cardio diagnostics holdings, inc. (CDIO)'s earnings per share (EPS) shows a declining trend, with the latest EPS at -0.98. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of CDIO?

    Cardio diagnostics holdings, inc. (CDIO)'s Free Cash Flow (FCF) for the period is -1.56M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 31.82% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.